explore -WSS

explore

author：explore 2025-08-11 16:24:49 - browse：84337

Illustration of doctor with an computer text bubble for a face for a story on Chat GPT and AI – health tech coverage from STAT — Mike Reddy for STAT

Health care companies are racing to incorporate generative AI tools into their product pipelines and IT systems after the technology displayed an ability to perform many tasks faster, cheaper — and sometimes better — than humans.

But the rush to harness the power of so-called large language models, which are trained on vast troves of data, is outpacing efforts to assess their value. AI experts are still trying to understand, and explain, how and why they work better than prior systems, and what blind spots might undermine their usefulness in medicine.

It remains unclear, for example, how well these models will perform, and what privacy and ethical quandaries will arise, when they’re exposed to new types of data, such as genetic sequences, CT scans, and electronic health records. Even knowing exactly how much data must be fed into a model to achieve peak performance on a given task is still largely guesswork.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： What’s missing from the debate over nursing home staff minimums

WSS

What STAT readers think about the FDA and patient advocacy

Medicare Advantage plans can’t deny care with AI, CMS warns

How to keep neuroscience’s past racism from being its future

Surgery pushed Ben Carson to fame

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Grail spinoff by Illumina should end disastrous merger attempt

focus

explore

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Virtual care provider acquires bankrupt Pear's prescription apps

Tori Bowie and the unacceptable rates of Black maternal death

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In Spain, a hospital brews its own CAR

What does generative AI mean for health care? We asked experts

Medicare Advantage beneficiaries sue Humana over algorithm use

ChatGPT in medicine: STAT answers readers' burning questions

Bernie brings in new pharma CEOs to talk drug prices

entertainment

The CDC's new social media misinformation war

AstraZeneca stays mum on Medicare drug pricing negotiations

Medicare drug price negotiation hasn't dried up venture capital

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Medicare drug price negotiation hasn't dried up venture capital

Bernie brings in new pharma CEOs to talk drug prices

entertainment

explore

hotspot

hotspot